Lymphocyte phenotype and function in the chronic fatigue syndrome.

S E Straus, S Fritz, J K Dale, B Gould, W Strober
Author Information
  1. S E Straus: Medical Virology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Abstract

Lymphocytes of 18 patients meeting the Centers for Disease Control (CDC) case definition for the chronic fatigue syndrome (CFS), 10 similar, chronically fatigued patients not fully conforming to the CDC case definition, and 17 matched, healthy individuals were studied to determine the presence of abnormalities of peripheral cell phenotype and function. Extensive phenotypic analyses of B- and T-cell subsets, natural killer (NK) cells, and macrophages were performed using single-, dual-, and three-color flow cytometry. Compared to controls, in CFS patients the percentage of CD4 T cells and CD4,CD45RA, or naive T cells, was reduced. The CD4,CD45RO, or memory T-cell, subset was numerically normal but expressed increased levels of adhesion markers (CD29, CD54, and CD58). CFS patient lymphocytes showed reduced proliferative responses to phytohemagglutinin, concanavalin A, and staphylococcal enterotoxin B. Lymphocytes from fatigue patients not meeting the CDC definition showed similar abnormalities. These data indicate that peripheral T cells manifest an increased state of differentiation in CFS and related conditions. This may arise as a consequence of an underlying neuropsychiatric and/or neuroendocrine disorder or because of exposure to antigens or superantigens of an infectious agent.

References

  1. N Engl J Med. 1988 Dec 29;319(26):1692-8 [PMID: 2849717]
  2. J Exp Med. 1987 Nov 1;166(5):1548-66 [PMID: 2824653]
  3. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S2-7 [PMID: 2020800]
  4. Crit Rev Neurobiol. 1988;4(2):157-78 [PMID: 3063394]
  5. Ann Intern Med. 1989 Mar 1;110(5):407-8 [PMID: 2916811]
  6. J Immunol. 1985 May;134(5):2989-94 [PMID: 3156923]
  7. J Infect Dis. 1989 Dec;160(6):1085-6 [PMID: 2584758]
  8. J Clin Immunol. 1985 Jan;5(1):46-54 [PMID: 2579970]
  9. N Engl J Med. 1988 Dec 29;319(26):1726-8 [PMID: 2849719]
  10. Cytokine. 1991 Jul;3(4):292-8 [PMID: 1873478]
  11. Lancet. 1991 Sep 21;338(8769):707-12 [PMID: 1679864]
  12. Med J Aust. 1989 Aug 7;151(3):117-8 [PMID: 2755370]
  13. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S12-8 [PMID: 1902321]
  14. BMJ. 1989 May 6;298(6682):1199-200 [PMID: 2502215]
  15. Scand J Immunol. 1991 Mar;33(3):319-27 [PMID: 1849315]
  16. J Immunol. 1987 Nov 15;139(10):3306-13 [PMID: 2824604]
  17. Biochemistry. 1988 Nov 29;27(24):8695-701 [PMID: 2853967]
  18. Ann Intern Med. 1985 Jan;102(1):1-7 [PMID: 2578266]
  19. J Immunol. 1988 Apr 1;140(7):2171-8 [PMID: 2965180]
  20. J Immunol. 1988 Mar 1;140(5):1401-7 [PMID: 2894392]
  21. J Clin Endocrinol Metab. 1991 Dec;73(6):1224-34 [PMID: 1659582]
  22. J Immunol. 1985 May;134(5):3082-8 [PMID: 2984282]
  23. Science. 1986 Oct 31;234(4776):541-2 [PMID: 3020689]
  24. J Immunol. 1988 Sep 1;141(5):1464-70 [PMID: 2970504]
  25. Am J Med. 1990 Nov;89(5):554-60 [PMID: 2239975]
  26. Psychol Med. 1992 Feb;22(1):45-53 [PMID: 1574566]
  27. Ann Intern Med. 1988 Oct 1;109(7):554-6 [PMID: 3421564]
  28. J Clin Endocrinol Metab. 1991 Jun;72(6):1382-7 [PMID: 1851185]
  29. Med J Aust. 1989 Aug 7;151(3):122-4 [PMID: 2787888]
  30. Ann Intern Med. 1985 Jan;102(1):7-16 [PMID: 2578268]
  31. Genomics. 1988 Jan;2(1):48-56 [PMID: 3384439]
  32. Immunol Today. 1988 Jul-Aug;9(7-8):195-9 [PMID: 2978373]
  33. J Clin Microbiol. 1990 Jun;28(6):1403-10 [PMID: 2166084]
  34. Ann Intern Med. 1989 Feb 15;110(4):321 [PMID: 2783643]
  35. Arch Gen Psychiatry. 1984 May;41(5):484-6 [PMID: 6609689]
  36. Annu Rev Immunol. 1989;7:339-69 [PMID: 2523715]
  37. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S26-31 [PMID: 1850541]
  38. Am J Med. 1990 Nov;89(5):561-8 [PMID: 2146875]
  39. JAMA. 1990 Jul 4;264(1):48-53 [PMID: 2162397]
  40. Ann Intern Med. 1988 Mar;108(3):387-9 [PMID: 2829679]
  41. JAMA. 1987 May 1;257(17):2335-6 [PMID: 3033340]
  42. Lancet. 1982 Jan 9;1(8263):61-4 [PMID: 6119490]
  43. J Immunol. 1985 Mar;134(3):1508-15 [PMID: 3155770]
  44. J Clin Endocrinol Metab. 1991 Feb;72(2):260-71 [PMID: 1846869]
  45. Lancet. 1988 Jun 4;1(8597):1288-9 [PMID: 2897551]
  46. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2922-6 [PMID: 1672770]
  47. J Abnorm Psychol. 1988 Nov;97(4):499-502 [PMID: 2904929]
  48. Microbiol Sci. 1988 Dec;5(12):366-9 [PMID: 2856301]
  49. South Med J. 1984 Nov;77(11):1376-82 [PMID: 6093268]
  50. J Infect Dis. 1990 Dec;162(6):1412-3 [PMID: 2230278]
  51. CMAJ. 1985 Oct 1;133(7):659-63 [PMID: 4042036]
  52. J Clin Endocrinol Metab. 1987 Nov;65(5):994-9 [PMID: 3499449]

Grants

  1. N01-CO-74102/NCI NIH HHS

MeSH Term

Adolescent
Adult
CD4-Positive T-Lymphocytes
Cell Adhesion Molecules
Cell Count
Fatigue Syndrome, Chronic
Female
Humans
Immunologic Memory
Leukocyte Common Antigens
Lymphocyte Activation
Lymphocyte Subsets
Lymphocytes
Male
Middle Aged
Phenotype
Prospective Studies

Chemicals

Cell Adhesion Molecules
Leukocyte Common Antigens

Word Cloud

Created with Highcharts 10.0.0patientsCFScellsCDCdefinitionfatigueCD4TLymphocytesmeetingcasechronicsyndromesimilarabnormalitiesperipheralphenotypefunctionT-cellreducedincreasedshowed18CentersDiseaseControl10chronicallyfatiguedfullyconforming17matchedhealthyindividualsstudieddeterminepresencecellExtensivephenotypicanalysesB-subsetsnaturalkillerNKmacrophagesperformedusingsingle-dual-three-colorflowcytometryComparedcontrolspercentageCD45RAnaiveCD45ROmemorysubsetnumericallynormalexpressedlevelsadhesionmarkersCD29CD54CD58patientlymphocytesproliferativeresponsesphytohemagglutininconcanavalinstaphylococcalenterotoxinBdataindicatemanifeststatedifferentiationrelatedconditionsmayariseconsequenceunderlyingneuropsychiatricand/orneuroendocrinedisorderexposureantigenssuperantigensinfectiousagentLymphocyte

Similar Articles

Cited By